News from the healthcare data industry
As more and more biotechs are looking into the potential applications of using real-world evidence in regulatory submissions, the European Medicines Agency is calling for more widespread adoption. EMA endorsed...
The use of registries as part of real-world evidence is critical for the clinical and regulatory development of medicines. Read this blog post to understand from our regulatory affairs managers...
Executive Summary The latest meeting of the DARWIN EU advisory board heard about moves to increase the number of RWD sources that can be analyzed and to improve the efficiency...
Executive Summary Neurodegenerative and cardiovascular diseases, along with cancer and early feasibility studies, are among the topics to be addressed by consortia interested in taking part in the EU’s latest...
Executive Summary England’s health technology appraisal institute, NICE, has published its real-world evidence framework.NICE LAUNCHES RWE FRAMEWORK With its newly published real-world evidence (RWE) framework, NICE, England’s health technology appraisal...
Health care providers collect vast amounts of electronic health information (EHI) that hold enormous potential for advancing science. However, that potential has been limited by a lack of incentives, imperatives, and...
Executive Summary A technical workshop is planned for later this year to identify common “use cases” for real-world evidence that are important to the European Medicines Agency, health technology assessment...
Improved screening, novel therapies and a focus on health equity can reduce cancer mortality by 50% in the next 25 years, but these must be underpinned by an investment in...
Decision-makers will have more data on which to judge the value of innovative medtech and healthtech products Read More: https://medtech.pharmaintelligence.informa.com/MT145554/NICE-Real-World-Evidence-Revolution-Will-Drive-UKs-Health-Care-Innovation
The bipartisan bill would reform the FDA pathway that provides early access to treatments for patients with serious and life-threatening conditions Washington, D.C.—U.S. Senators Susan Collins (R-ME) and Tim Kaine...